On-demand MEDTalks: Navigating the changing landscape of pneumococcal disease in Australia
You need to login to participate in this education.
This education is accredited: RACGP 1 CPD, ACRRM 1 CME PD.
How high are pneumococcal vaccination rates at your practice?
According to the National Centre for Immunisation Research and Surveillance (NCIRS), coverage of adult vaccination in Australia is suboptimal,¹ with only one in five eligible adults receiving pneumococcal vaccinations in 2021.²
Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and a vaccine expert will outline key issues in primary care, relevant pneumococcal serotypes in Australia and considerations when choosing from vaccines that are now available. Finally, a lively panel Q&A will leave you with practical tips for the optimal prevention of this disease in your at-risk patients.
By completing this learning activity, participants will be able to:
- Understand the at-risk groups for invasive pneumococcal disease (IPD) and community-acquired pneumonia (CAP) in Australia.
- Rationalise and overcome barriers to the use of guideline-recommended pneumococcal vaccines in adults.
- Distinguish between recommended pneumococcal vaccines and asses their effectiveness against relevant serotypes in Australia.
- Recall at-risk patients for whom pneumococcal vaccines are recommended and educate them about the importance of receiving a vaccination.
Presented by: A/Prof Gary Kilov, Dr Chee Khoo, Prof Paul Van Buynder, Dr Ralph Audehm
This activity is sponsored by MSD Australia.
- National Centre for Immunisation Research and Surveillance (NCIRS) Australia. Immunisation coverage and evaluation reports. Immunisation coverage data and reports | NCIRS. Accessed March 2023.
- Menzies, R et al. The impact of the changing pneumococcal national immunisation program among older Australians. Vaccine. 2021 Jan 22;39(4):720-728.
|On-demand MEDTalks: Navigating the changing landscape of pneumococcal disease in Australia - Education
|On-demand MEDTalks: Navigating the changing landscape of pneumococcal disease in Australia - Evaluation